Anebulo Pharmaceuticals Announces Final Results of Oversubscribed Tender Offer

Anebulo Pharmaceuticals announced the final results of its voluntary self-tender offer to purchase 300,000 shares of its common stock, which expired on January 26, 2026. A total of 4,907,881 shares were properly tendered, with the offer being oversubscribed. The company will purchase shares based on the final count by Broadridge Corporate Issuer Solutions.